DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lv X, Dong Y, Hu L, Lu F, Zhou C, Qin S.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): a systematic review.
Endocrinol Diabetes Metab 2020;
3 (03) e00163
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.